244 related articles for article (PubMed ID: 26009281)
81. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.
Yang M; Niu X; Yang X; Sun Y; Su W; Zhang J; Wu Q; Wang Y; Zhang Q; Ji H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1469-1478. PubMed ID: 36847415
[TBL] [Abstract][Full Text] [Related]
82. Comparative gene-expression profiling of the large cell variant of gastrointestinal marginal-zone B-cell lymphoma.
Barth TFE; Kraus JM; Lausser L; Flossbach L; Schulte L; Holzmann K; Kestler HA; Möller P
Sci Rep; 2017 Jul; 7(1):5963. PubMed ID: 28729720
[TBL] [Abstract][Full Text] [Related]
83. Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma.
Kwee I; Capello D; Rinaldi A; Rancoita PM; Bhagat G; Greiner TC; Spina M; Gloghini A; Chan WC; Paulli M; Zucca E; Tirelli U; Carbone A; Gaidano G; Bertoni F
Leuk Lymphoma; 2012 Jan; 53(1):71-6. PubMed ID: 21787262
[TBL] [Abstract][Full Text] [Related]
84. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.
Lu X; Chen J; Sasmono RT; Hsi ED; Sarosiek KA; Tiganis T; Lossos IS
Mol Cell Biol; 2007 Mar; 27(6):2166-79. PubMed ID: 17210636
[TBL] [Abstract][Full Text] [Related]
85. Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract][Full Text] [Related]
86. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
Michaelsen TY; Richter J; Brøndum RF; Klapper W; Johnsen HE; Albertsen M; Dybkær K; Bøgsted M
Blood Adv; 2018 Jul; 2(13):1542-1546. PubMed ID: 29967255
[TBL] [Abstract][Full Text] [Related]
87. Novel therapeutic targets in diffuse large B-cell lymphoma.
Lenz G
EJC Suppl; 2013 Sep; 11(2):262-3. PubMed ID: 26217138
[TBL] [Abstract][Full Text] [Related]
88. Prognostic significance of metallothionein in B-cell lymphomas.
Poulsen CB; Borup R; Borregaard N; Nielsen FC; Møller MB; Ralfkiaer E
Blood; 2006 Nov; 108(10):3514-9. PubMed ID: 16868254
[TBL] [Abstract][Full Text] [Related]
89. Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance.
Ahmed S; Glover P; Taylor J; Sha C; Care MA; Tooze R; Davies A; Westhead DR; Johnson PWM; Burton C; Barrans SL
Br J Haematol; 2021 Feb; 192(3):599-604. PubMed ID: 33249557
[TBL] [Abstract][Full Text] [Related]
90. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
Brown PJ; Ashe SL; Leich E; Burek C; Barrans S; Fenton JA; Jack AS; Pulford K; Rosenwald A; Banham AH
Blood; 2008 Mar; 111(5):2816-24. PubMed ID: 18077790
[TBL] [Abstract][Full Text] [Related]
91. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
[TBL] [Abstract][Full Text] [Related]
92. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
Ramachandran P; Sahni S; Wang JC
J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
[TBL] [Abstract][Full Text] [Related]
93. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins.
Hiratsuka T; Ito S; Sakai R; Yokose T; Endo T; Daigo Y; Miyagi Y; Tsuruyama T
Clin Proteomics; 2023 Sep; 20(1):36. PubMed ID: 37705009
[TBL] [Abstract][Full Text] [Related]
94. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.
Dubois S; Tesson B; Mareschal S; Viailly PJ; Bohers E; Ruminy P; Etancelin P; Peyrouze P; Copie-Bergman C; Fabiani B; Petrella T; Jais JP; Haioun C; Salles G; Molina TJ; Leroy K; Tilly H; Jardin F;
EBioMedicine; 2019 Oct; 48():58-69. PubMed ID: 31648986
[TBL] [Abstract][Full Text] [Related]
95. Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.
Leivonen SK; Taskinen M; Cervera A; Karjalainen-Lindsberg ML; Delabie J; Holte H; Lehtonen R; Hautaniemi S; Leppä S
Blood Cancer J; 2017 Aug; 7(8):e596. PubMed ID: 28841210
[TBL] [Abstract][Full Text] [Related]
96. Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12.
Nagao T; Yoshifuji K; Sadato D; Motomura Y; Saito M; Yamamoto K; Yamamoto K; Nogami A
Exp Hematol; 2022 Dec; 116():37-49. PubMed ID: 36191884
[TBL] [Abstract][Full Text] [Related]
97. De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression.
Igawa T; Sato Y; Takata K; Iwaki N; Tanaka T; Asano N; Maeda Y; Orita Y; Nakamura N; Nakamura S; Yoshino T
Diagn Pathol; 2013 May; 8():81. PubMed ID: 23675804
[TBL] [Abstract][Full Text] [Related]
98. DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells.
Jabłońska E; Białopiotrowicz E; Szydłowski M; Prochorec-Sobieszek M; Juszczyński P; Szumera-Ciećkiewicz A
Exp Hematol; 2020 Aug; 88():56-67.e2. PubMed ID: 32702393
[TBL] [Abstract][Full Text] [Related]
99. Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
Rui L; Drennan AC; Ceribelli M; Zhu F; Wright GW; Huang DW; Xiao W; Li Y; Grindle KM; Lu L; Hodson DJ; Shaffer AL; Zhao H; Xu W; Yang Y; Staudt LM
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7260-E7267. PubMed ID: 27799566
[TBL] [Abstract][Full Text] [Related]
100. A Case of CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Secondary to Chronic Lymphedema.
Sun L; Sun Y; Xin W; He J; Hu Y; Zhang H; Yu J; Zhang JA
Am J Dermatopathol; 2022 Mar; 44(3):179-182. PubMed ID: 35171885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]